Three Prognostic Biomarkers Correlate with Immune Checkpoint Blockade Response in Bladder Urothelial Carcinoma

Figure 4

Nomogram for prediction of the outcome of BLCA patients. (a, b) Univariate and multivariate Cox regression analyses were applied to assess the independent predictive value of the three-gene signature. (c) Nomogram for prediction the 1-year, 3-year, and 5-year overall survival rate of BLCA patients. (d) The calibration plots of the nomogram. BLCA: bladder urothelial carcinoma.

(a)

(b)

(c)

(d)